Dopamine inhibits adenylate cyclase in human prolactin-secreting pituitary adenomas - PubMed (original) (raw)
. 1979 Mar 15;278(5701):252-4.
doi: 10.1038/278252a0.
- PMID: 423973
- DOI: 10.1038/278252a0
Dopamine inhibits adenylate cyclase in human prolactin-secreting pituitary adenomas
P De Camilli et al. Nature. 1979.
No abstract available
Similar articles
- A defect in catecholamine neurons in patients with prolactin-secreting pituitary adenoma.
Van Loon GR. Van Loon GR. Lancet. 1978 Oct 21;2(8095):868-71. doi: 10.1016/s0140-6736(78)91572-6. Lancet. 1978. PMID: 81414 - Presence of high affinity dopamine receptors in estrone-induced, prolactin-secreting rat pituitary adenomas: a model for human prolactinomas.
Eljarmak D, Marchisio AM, Lis M, Collu R. Eljarmak D, et al. Horm Res. 1985;21(2):107-16. doi: 10.1159/000180034. Horm Res. 1985. PMID: 3920132 - Failure of dopamine and bromocriptine to affect prolactin release and cell growth in the dopamine receptor-deficient 235-1 clone.
Cronin MJ, Perkins SN, Keefer DA, MacLeod RM. Cronin MJ, et al. Mol Cell Endocrinol. 1982 Oct;28(2):229-46. doi: 10.1016/0303-7207(82)90034-x. Mol Cell Endocrinol. 1982. PMID: 7128925 - Dopamine receptors in the normal and abnormal anterior pituitary gland.
Cronin MJ, Evans WS. Cronin MJ, et al. Clin Endocrinol Metab. 1983 Mar;12(1):15-30. doi: 10.1016/s0300-595x(83)80027-9. Clin Endocrinol Metab. 1983. PMID: 6303644 Review. No abstract available. - Positron emission tomography applied in the study of pituitary adenomas.
Muhr C, Bergström M. Muhr C, et al. J Endocrinol Invest. 1991 Jun;14(6):509-28. doi: 10.1007/BF03346855. J Endocrinol Invest. 1991. PMID: 1837798 Review. No abstract available.
Cited by
- How changes in dopamine D2 receptor levels alter striatal circuit function and motivation.
Simpson EH, Gallo EF, Balsam PD, Javitch JA, Kellendonk C. Simpson EH, et al. Mol Psychiatry. 2022 Jan;27(1):436-444. doi: 10.1038/s41380-021-01253-4. Epub 2021 Aug 12. Mol Psychiatry. 2022. PMID: 34385603 Free PMC article. Review. - Roles of the Functional Interaction between Brain Cholinergic and Dopaminergic Systems in the Pathogenesis and Treatment of Schizophrenia and Parkinson's Disease.
Acharya S, Kim KM. Acharya S, et al. Int J Mol Sci. 2021 Apr 21;22(9):4299. doi: 10.3390/ijms22094299. Int J Mol Sci. 2021. PMID: 33919025 Free PMC article. Review. - Effects of nicotine on DARPP-32 and CaMKII signaling relevant to addiction.
Lee AM, Picciotto MR. Lee AM, et al. Adv Pharmacol. 2021;90:89-115. doi: 10.1016/bs.apha.2020.09.002. Epub 2020 Oct 6. Adv Pharmacol. 2021. PMID: 33706940 Free PMC article. Review. - Somatostatin-Dopamine Chimeric Molecules in Neuroendocrine Neoplasms.
Cantone MC, Dicitore A, Vitale G. Cantone MC, et al. J Clin Med. 2021 Feb 1;10(3):501. doi: 10.3390/jcm10030501. J Clin Med. 2021. PMID: 33535394 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources